Literature DB >> 6941242

Isolation of functional human coagulation factor V by using a hybridoma antibody.

J A Katzmann, M E Nesheim, L S Hibbard, K G Mann.   

Abstract

Spleen cells obtained from mice immunized with partially purified human coagulation Factor V were fused with NS-1 mouse myeloma cells, and hybrids were selected. Culture media were screened for anti-Factor V activity, and an antibody-positive clone was obtained and passaged as an ascites tumor in mice. The ascitic fluid from the hybridoma-bearing mouse could be diluted 1:10(6) before losing reactivity in an anti-Factor V radioimmunoassay. When immobilized on agarose, the monoclonal antibody quantitatively removed Factor V activity from human plasma. Factor V activity could be eluted with 1.2 M NaCl at pH 6.5. Homogeneous Factor V was isolated by chromatography of barium citrate-adsorbed, polyethylene glycol 6000 precipitated plasma on the antibody column followed by chromatography on phenyl-Sepharose. The isolated Factor V exhibited a single band upon gel electrophoresis in sodium dodecyl sulfate with an apparent Mr comparable to that of bovine Factor V (330,000). Upon exposure to thrombin, the activity of Factor V increased 53-fold when measured in Factor V-deficient plasma. This increased activity was associated with discrete proteolytic cleavages of the parent molecule.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6941242      PMCID: PMC319011          DOI: 10.1073/pnas.78.1.162

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  The isolation of factor V from bovine plasma.

Authors:  M P Esnouf; F Jobin
Journal:  Biochem J       Date:  1967-03       Impact factor: 3.857

2.  Porcine Willebrand factor: a population of multimers.

Authors:  D N Fass; G J Knutson; E J Bowie
Journal:  J Lab Clin Med       Date:  1978-02

3.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

4.  Multiple active forms of thrombin. I. Partial resolution, differential activities, and sequential formation.

Authors:  K G Mann; C M Heldebrant; D N Fass
Journal:  J Biol Chem       Date:  1971-10-10       Impact factor: 5.157

5.  The preparation and properties of a stable factor V from bovine plasma.

Authors:  P G Barton; D J Hanahan
Journal:  Biochim Biophys Acta       Date:  1967-04-11

6.  The activation of factor V by factor Xa or alpha-chymotrypsin and comparison with thrombin and RVV-V action. An improved factor V isolation procedure.

Authors:  C M Smith; D J Hanahan
Journal:  Biochemistry       Date:  1976-05-04       Impact factor: 3.162

7.  Studies on the formation of the prothrombin-converting complex.

Authors:  F Jobin; M P Esnouf
Journal:  Biochem J       Date:  1967-03       Impact factor: 3.857

8.  Phospholipid-binding properties of bovine factor V and factor Va.

Authors:  J W Bloom; M E Nesheim; K G Mann
Journal:  Biochemistry       Date:  1979-10-02       Impact factor: 3.162

9.  Thrombin-catalyzed activation of single chain bovine factor V.

Authors:  M E Nesheim; K G Mann
Journal:  J Biol Chem       Date:  1979-02-25       Impact factor: 5.157

10.  The role of phospholipids and factor Va in the prothrombinase complex.

Authors:  J Rosing; G Tans; J W Govers-Riemslag; R F Zwaal; H C Hemker
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

View more
  31 in total

1.  Coagulation procofactor activation by factor XIa.

Authors:  M F Whelihan; T Orfeo; M T Gissel; K G Mann
Journal:  J Thromb Haemost       Date:  2010-05-04       Impact factor: 5.824

2.  Membrane binding events in the initiation and propagation phases of tissue factor-initiated zymogen activation under flow.

Authors:  Laura M Haynes; Yves C Dubief; Kenneth G Mann
Journal:  J Biol Chem       Date:  2011-12-20       Impact factor: 5.157

3.  Taking the thrombin "fork".

Authors:  Kenneth G Mann
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-07       Impact factor: 8.311

4.  Electron microscopy of human factor V and factor VIII: correlation of morphology with domain structure and localization of factor V activation fragments.

Authors:  W E Fowler; P J Fay; D S Arvan; V J Marder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides.

Authors:  Matthew W Bunce; Mettine H A Bos; Sriram Krishnaswamy; Rodney M Camire
Journal:  J Biol Chem       Date:  2013-09-06       Impact factor: 5.157

6.  Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin.

Authors:  W H Kane; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

7.  Complete cDNA and derived amino acid sequence of human factor V.

Authors:  R J Jenny; D D Pittman; J J Toole; R W Kriz; R A Aldape; R M Hewick; R J Kaufman; K G Mann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition.

Authors:  Anetta Undas; Matthew Gissel; Beata Kwasny-Krochin; Piotr Gluszko; Kenneth G Mann; Kathleen E Brummel-Ziedins
Journal:  Thromb Haemost       Date:  2010-06-30       Impact factor: 5.249

9.  The influence of von Willebrand factor on factor VIII activity measurements.

Authors:  S Butenas; B Parhami-Seren; K G Mann
Journal:  J Thromb Haemost       Date:  2008-10-29       Impact factor: 5.824

10.  Proteolysis of plasma-derived factor V following its endocytosis by megakaryocytes forms the platelet-derived factor V/Va pool.

Authors:  F Ayombil; S Abdalla; P B Tracy; B A Bouchard
Journal:  J Thromb Haemost       Date:  2013-08       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.